Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TR-Pharm

www.trpharm.com

Latest From TR-Pharm

Interview: CrystalGenomics, First Korean Bioventure To ‘Go All The Way’

After reaching milestones by launching a novel osteoarthritis drug and licensing out an AML candidate to a US partner, CrystalGenomics’ CEO talks to Scrip about what else is in store for the South Korean bioventure in 2017 and beyond.

Commercial Companies

Turkey Jostles For Slice Of Biologics Manufacturing Pie

Many local pharma companies in Turkey have been launching capital investments in new production facilities for biologics and biosimilars in the hope of attracting new foreign partners and have already met with some success, but a number of obstacles remain.

Turkey Manufacturing

Will Turkey’s Strong Biotech Development Steps Be Effective?

The Turkish market for biotech drugs and biologics is growing strongly but most are imported and the country is now determined to develop its infrastructure for local manufacturing through a series of moves. While there has been some progress, it is not yet certain if this is enough to meet high official expectations and convince investors.

BioPharmaceutical Turkey

Indo-Turkish Biosimilar Connections Build

More Indian firms appear keen to target the Turkish market for biosimilars. After Dr Reddy's outlined its plans earlier this year, Zydus Cadila has now firmed up an alliance with Turkey's Eczacibasi Ilac Pazarlama AS for biosimilars especially in the oncology segment.

Companies Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Turkey
  • Parent & Subsidiaries
  • TR-Pharm
  • Senior Management
  • Ismet Ince, Dir., Fin. & Bus. Dev.
    Orkun Eray, PhD, Medical Dir.
  • Contact Info
  • TR-Pharm
    Phone: 212 386 31 30
    Esentepe Mahallesi, Büyükdere Caddesi
    Kanyon 185
    Istanbul, 14 34394
    Turkey
Advertisement
Advertisement
UsernamePublicRestriction

Register